Senate Health, Education, Labor & Pensions Committee Issues Testimony From Novo Nordisk President Jorgensen
October 17, 2024
October 17, 2024
WASHINGTON, Oct. 17 -- The Senate Health, Education, Labor and Pensions Committee released the following testimony by Lars Fruergaard Jorgensen, president and CEO of Novo Nordisk from a Sept. 24, 2024, hearing entitled "Why Is Novo Nordisk Charging Americans With Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?":
* * *
Chairman Sanders, Ranking Member Cassidy, and Members of the Committee, thank you for the opportunity to participate in to . . .
* * *
Chairman Sanders, Ranking Member Cassidy, and Members of the Committee, thank you for the opportunity to participate in to . . .